We are live on ! Find out more
LAB icon

Standard BioTools
LAB

65 hedge funds and large institutions have $42.5M invested in Standard BioTools in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 28 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

7.68% less ownership

Funds ownership: 56.8% → 49.12% (-7.7%)

24% less funds holding

Funds holding: 86 → 65 (-21)

39% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 28

39% less capital invested

Capital invested by funds: $70.2M → $42.5M (-$27.7M)

54% less call options, than puts

Call options by funds: $44K | Put options by funds: $96K

84% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 25

Holders
65
Holders Change
-21
Holders Change %
-24.42%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
17
Reduced
28
Closed
25
Calls
$44K
Puts
$96K
Net Calls
-$52K
Net Calls Change
+$191K

Top Buyers

1
JCP
Jennifer C. Price
+$921K
2
Neuberger Berman Group
Neuberger Berman Group
New York
+$600K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$600K
4
BCM
Bridgeway Capital Management
Texas
+$245K
5
XT
XTX Topco
Cayman Islands
+$210K

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$3.18M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.82M
3
PVI
Pura Vida Investments
New York
-$902K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$860K
5
Millennium Management
Millennium Management
New York
-$657K
Name Holding Trade Value Shares
Change 		Change in
Stake
IP
26
Intellectus Partners
California
$91K -$19.1K -12,600 -13%
Two Sigma Advisers
27
Two Sigma Advisers
New York
$82K +$1.21K +800 +1%
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$68K -$9.36K -6,192 -9%
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$68K +$66.7K +44,100 +249%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$66K +$124 +82 +0.1%
BCPWM
31
Bradley & Co Private Wealth Management
Florida
$55K – – –
Goldman Sachs
32
Goldman Sachs
New York
$51K -$293K -193,841 -81%
Group One Trading
33
Group One Trading
Illinois
$36K -$85.7K -56,702 -63%
Allspring Global Investments
34
Allspring Global Investments
North Carolina
$36K +$15K +9,912 +42%
SEI Investments
35
SEI Investments
Pennsylvania
$32K +$1.29K +855 +3%
Charles Schwab
36
Charles Schwab
California
$30K – – –
LP
37
LMR Partners
United Kingdom
$30K – – –
Jane Street
38
Jane Street
New York
$28K -$239K -158,337 -86%
Principal Financial Group
39
Principal Financial Group
Iowa
$26K -$39.6K -26,216 -52%
Prudential Financial
40
Prudential Financial
New Jersey
$24K – – –
GF
41
Gabelli Funds
New York
$23K – – –
UBS Group
42
UBS Group
Switzerland
$21K -$15.6K -10,344 -35%
SFI
43
Susquehanna Fundamental Investments
Pennsylvania
$20K +$27.4K +18,141 New
EGM
44
Engineers Gate Manager
New York
$19K -$67.9K -44,909 -72%
MHC
45
Meyer Handelman Company
New York
$19K – – –
Commonwealth Equity Services
46
Commonwealth Equity Services
Massachusetts
$17K – – –
AGM
47
Alpine Global Management
New York
$15K – – –
LCS
48
Levin Capital Strategies
New York
$15K – – –
Osaic Holdings
49
Osaic Holdings
Arizona
$14K +$2.6K +1,720 +16%
Citadel Advisors
50
Citadel Advisors
Florida
$13K -$380K -251,248 -95%
1
2
3 4

LAB Hedge Fund Activity: Q3 2022 in Review

65 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2022, worth a combined $42.5M — down 39% from $70.2M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of LAB and 4 opened new positions — a net loss of 21 holders — while 28 trimmed existing stakes and 17 added.

The largest buyer was Jennifer C. Price, adding an estimated $921K. The largest seller was RA Capital Management, exiting entirely with an estimated $3.18M sold.

  • 65 institutional investors held Standard BioTools (LAB) as of Q3 2022, down from 86 in Q2 2022.
  • Funds reported $42.5M of Standard BioTools stock for Q3 2022, down 39% quarter-over-quarter.
  • 4 funds opened new Standard BioTools positions in Q3 2022 and 25 closed out, a net change of -21 holders.
  • The largest Standard BioTools buyer in Q3 2022 was Jennifer C. Price, an estimated $921K added.
  • The largest Standard BioTools seller in Q3 2022 was RA Capital Management, an estimated $3.18M sold.

Based on aggregated 13F filings for Q3 2022.